Full text is available at the source.
Abstract
Incretin-targeted therapies may provide a promising approach to obesity management.
- Obesity is influenced by a combination of metabolic, environmental, and psychosocial factors.
- Key hormones, such as glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), amylin, and glucagon, play crucial roles in energy balance, appetite regulation, and insulin secretion.
- Emerging therapies include dual and triple receptor agonists that target these hormones.
- Future developments may focus on personalized medicine, including innovative drug-delivery systems and new therapeutic targets.
Simplified